1 on 3 (CCM3) results in an autosomal dominant cerebrovascular disorder.

2  activity may hold therapeutic potential for cerebrovascular disorders.

3 eral autosomal dominantly inherited forms of cerebrovascular disorders.

4 iated with underlying hereditary or acquired cerebrovascular disorders.

5 sformed diagnosis, therapy, and prognosis of cerebrovascular disorders.

6 e alkaloid vincamine, has long been used for cerebrovascular disorders and cognitive impairment.

7 e combination of keywords Alzheimer disease, cerebrovascular disorders, and drug therapy, and the com

8 drinking, ethanol, cerebrovascular accident, cerebrovascular disorders, and intracranial embolism and

9 rieved using MEDLINE (search terms, aspirin, cerebrovascular disorders, and stroke), bibliographies o

10 he measurement of CBF has obvious utility in cerebrovascular disorders, because CBF is closely couple

11                  Moyamoya disease (MMD) is a cerebrovascular disorder characterized by occlusive lesi

12    Major changes in the treatment of various cerebrovascular disorders have occurred with improvement

13 e report on 3 babies with different neonatal cerebrovascular disorders including ischemic infarction

14 t the genotypes, genetic characterization of cerebrovascular disorders is valuable for understanding